These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Long-term therapy with human insulin. Clinical experiences]. Sachse G; Mäser E; Federlin K Dtsch Med Wochenschr; 1985 Mar; 110(11):403-6. PubMed ID: 3884307 [TBL] [Abstract][Full Text] [Related]
24. Premixed biphasic insulin analogs - a choice for pediatric patients with type 2 diabetes rather than type 1 diabetes? Danne T Pediatr Diabetes; 2006 Feb; 7(1):1-3. PubMed ID: 16489967 [No Abstract] [Full Text] [Related]
26. [When oral antidiabetics are no longer enough. Tablets plus basal insulin]. Meissner T MMW Fortschr Med; 2001 Aug; 143(31-32):46. PubMed ID: 11556193 [No Abstract] [Full Text] [Related]
27. [Practice tips for modern insulin therapy. "Bed time insulins without adverse morning aftereffect"]. Bottermann P MMW Fortschr Med; 1999 Dec; 141(48):40-2. PubMed ID: 10728299 [No Abstract] [Full Text] [Related]
28. [Treatment of type I diabetics with a combination of Superdep + DEP + NZI and an adjustment of the insulin dosage by means of a Biostator]. Kábrt J; Masek Z; Páv J; Skrha J; Hodinár A Vnitr Lek; 1986 Apr; 32(4):373-8. PubMed ID: 3523974 [No Abstract] [Full Text] [Related]
29. Synthesis and evaluation of triazole-linked poly(ε-caprolactone)-graft-poly(2-methyl-2-oxazoline) copolymers as potential drug carriers. Guillerm B; Darcos V; Lapinte V; Monge S; Coudane J; Robin JJ Chem Commun (Camb); 2012 Mar; 48(23):2879-81. PubMed ID: 22311101 [TBL] [Abstract][Full Text] [Related]
30. [Drug delivery system for diabetes]. Yamasaki Y Nihon Rinsho; 1998 Mar; 56(3):748-51. PubMed ID: 9549368 [TBL] [Abstract][Full Text] [Related]
31. An efficient pH sensitive oral insulin delivery system enhanced by deoxycholic acid. Zhao L; Ding J; He P; Xiao C; Tang Z; Zhuang X; Chen X J Control Release; 2011 Nov; 152 Suppl 1():e184-6. PubMed ID: 22195840 [No Abstract] [Full Text] [Related]
32. Rationale for using combinations of short-acting insulin analogue and NPH insulin at mealtime in the treatment of type 1 diabetes mellitus. Bolli GB J Pediatr Endocrinol Metab; 1999; 12 Suppl 3():737-44. PubMed ID: 10626264 [No Abstract] [Full Text] [Related]
33. [Are des-Phe-insulin-containing insulin combinations preferable to regular trade preparations?]. Sachse G; Federlin K Med Klin; 1981 May; 76(11):319-23. PubMed ID: 7017364 [TBL] [Abstract][Full Text] [Related]
34. [Long-acting insulin analog, glargine, in the treatment of type 1 diabetes]. Tuomi T Duodecim; 2004; 120(1):88-92. PubMed ID: 14976814 [No Abstract] [Full Text] [Related]
35. Multiple daily insulin regimen using insulin glargine in type 1 diabetic Saudi children. Bin-Abbas BS; Al-Agha AE; Sakati NA; Al-Ashwal AA Saudi Med J; 2006 Feb; 27(2):262-4. PubMed ID: 16501691 [No Abstract] [Full Text] [Related]
36. Re: post-prandial hypoglycaemia due to insulin lispro or insulin aspart. Burden AC Diabet Med; 2004 Dec; 21(12):1373. PubMed ID: 15569146 [No Abstract] [Full Text] [Related]
37. [Current technologies and strategies in the treatment of insulin-dependent diabetes mellitus]. Kuntschen F; Zumsteg U Schweiz Med Wochenschr Suppl; 1994; 60():76-80. PubMed ID: 8016619 [No Abstract] [Full Text] [Related]
38. Polymerizing Insulin with Photocleavable Linkers to Make Light-Sensitive Macropolymer Depot Materials. Sarode BR; Jain PK; Friedman SH Macromol Biosci; 2016 Aug; 16(8):1138-46. PubMed ID: 27171861 [TBL] [Abstract][Full Text] [Related]